William Fearon sits down with C. Michael Gibson to discuss the 3 year results from FAME 2. FAME 2: 3-Year Clinical and Cost-Effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback